{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T21:49:18Z","timestamp":1792619358955,"version":"4.5.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T00:00:00Z","timestamp":1655164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec>\n                    <jats:title>Background and Objectives<\/jats:title>\n                    <jats:p>Short-bowel syndrome (SBS) results from the loss of a significant portion of the small intestine leading to a state of malabsorption. After an intestinal loss, there is a process of adaptation involving the Glucagon-Like Peptide-2 (GLP-2), an enteroendocrine peptide also involved in nutrient absorption. Teduglutide is a recombinant analog of GLP-2 approved in 2016 to treat selected SBS pediatric patients who are dependent on parenteral support. The present systematic review aims to evaluate the efficacy of Teduglutide in pediatric patients with SBS in reducing the need for parenteral nutrition (PN).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>We performed a literature search on MEDLINE and Embase to include articles up to November 2021. We included articles that involved using Teduglutide in the SBS pediatric population to define its efficacy in reducing the need for PN. The key words used were GLP-2, teduglutide, child.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Fourteen studies completely fulfilled the inclusion criteria. Two hundred 23 patients were treated with Teduglutide, and the median duration of treatment was 45 weeks (IQR: 36\u201352.5 weeks). One-hundred and fifty-two patients were treated with 0.05 mg\/Kg\/d of subcutaneous Teduglutide, 38 received 0.025 mg\/Kg\/d and 8 received either 0.125 mg\/Kg\/d or 0.20 mg\/Kg\/d. A total of 36 patients achieved enteral autonomy (EA) after a median of 24 weeks of treatment (IQR: 24\u201348 weeks) and 149 patients showed a reduction in PN needs in terms of volume, calories, or hours per day. Eleven studies reported complications: gastrointestinal were the most common, with 89 cases reported in treated patients and 11 in non-treated patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Teduglutide appears safe and effective in reducing PN requirements and improving EA in the pediatric population. However, more studies are needed to understand its efficacy in the long term and after discontinuation and possible complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>\n                      [\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/prospero\/<\/jats:ext-link>\n                      ], identifier [CRD42022301593].\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnut.2022.866518","type":"journal-article","created":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T07:02:22Z","timestamp":1655190142000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Use of Teduglutide in Children With Intestinal Failure: A Systematic Review"],"prefix":"10.3389","volume":"9","author":[{"given":"Francesca","family":"Gigola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Chiara","family":"Cianci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Cirocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Chiara","family":"Ranucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Del Riccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Coletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Morabito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/MPG.0000000000003329","article-title":"Longitudinal development of health-related quality of life and fatigue in children on home parenteral nutrition.","volume":"74","author":"Nagelkerke","year":"2022","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"B2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s00595-020-02207-z","article-title":"An overview of the current management of short-bowel syndrome in pediatric patients.","volume":"52","author":"Muto","year":"2022","journal-title":"Surg Today."},{"key":"B3","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.jpedsurg.2009.01.031","article-title":"Establishing norms for intestinal length in children.","volume":"44","author":"Struijs","year":"2009","journal-title":"J Pediatr Surg."},{"key":"B4","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1055\/s-0038-1660850","article-title":"Institutional experience with spiral intestinal lengthening and tailoring.","volume":"29","author":"Coletta","year":"2018","journal-title":"Eur J Pediatr Surg."},{"key":"B5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jpeds.2004.02.030","article-title":"Long-term parenteral nutritional support and intestinal adaptation in children with short bowel syndrome: a 25-year experience.","volume":"145","author":"Quir\u00f3s-Tejeira","year":"2004","journal-title":"J Pediatr."},{"key":"B6","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1053\/j.sempedsurg.2009.07.010","article-title":"The dilated bowel: a liability and an asset.","volume":"18","author":"Bianchi","year":"2009","journal-title":"Semin Pediatr Surg."},{"key":"B7","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1080\/00365520802538195","article-title":"Glucagon-like peptide-2 increases mesenteric blood flow in humans.","volume":"44","author":"Bremholm","year":"2009","journal-title":"Scand J Gastroenterol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1139\/y03-107","article-title":"Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2.","volume":"81","author":"Brubaker","year":"2003","journal-title":"Can J Physiol Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.jpedsurg.2017.01.034","article-title":"A safety and pharmacokinetic dosing study of glucagon-like peptide 2 in infants with intestinal failure.","volume":"52","author":"Sigalet","year":"2017","journal-title":"J Pediatr Surg."},{"key":"B10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2174\/1389203043486946","article-title":"Glucagon-like peptide 2 (GLP-2), an intestinotrophic mediator.","volume":"5","author":"Thulesen","year":"2004","journal-title":"Curr Protein Pept Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1136\/gut.2004.061440","article-title":"Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients.","volume":"54","author":"Jeppesen","year":"2005","journal-title":"Gut."},{"key":"B12","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1177\/0148607115609566","article-title":"Safety and dosing study of glucagon-like peptide 2 in children with intestinal failure.","volume":"41","author":"Sigalet","year":"2015","journal-title":"J Parenter Enteral Nutr."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2016.10.027","article-title":"Short-term results of teduglutide therapy in children with short bowel syndrome.","volume":"72","author":"Ribeiro-Mour\u00e3o","year":"2021","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"B16","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1097\/MPG.0000000000002899","article-title":"Experience with teduglutide in pediatric short bowel syndrome: first real-life data.","volume":"71","author":"Ramos Boluda","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"B17","first-page":"391","article-title":"Intestinal rehabilitation in Latin-America, report of the first paediatric case treated with Teduglutide, fifty weeks of follow up.","volume":"66","author":"Rumbo","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"B18","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jpeds.2016.10.027","article-title":"Outcomes from a 12-week, open-label, multicenter clinical trial of teduglutide in pediatric short bowel syndrome.","volume":"181","author":"Carter","year":"2017","journal-title":"J Pediatr."},{"key":"B19","article-title":"Initial experience with teduglutide in pediatric intestinal failure.","volume":"72","author":"Busoni","year":"2021","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"B20","author":"Ferreiro","year":"2019","journal-title":"Teduglutide?: The New Weapon in Pediatric Short Bowel Syndrome Pediatric Gastroenterology, Hepatology and Nutrition Unit."},{"key":"B21","first-page":"11","article-title":"A prospective, open-label, long-term safety and efficacy study of teduglutide in pediatric patients with short bowel syndrome-associated intestinal failure: 6-month interim analysis.","volume":"69","author":"Mercer","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"B22","first-page":"2019","article-title":"A prospective, open-label, long-term safety and efficacy study of teduglutide in pediatric patients with short bowel syndrome-associated intestinal failure: 6-month interim analysis (SHP633-303).","volume":"69","author":"Hill","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"B23","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1097\/01.tp.0000757952.00163.8c","article-title":"Single-center experience with teduglutide in pediatric patients with short bowel syndrome associated intestinal failure.","volume":"105","author":"Kinberg","year":"2021","journal-title":"Transplantation."},{"key":"B24","first-page":"132","article-title":"Intestinal adaptation in children with short bowel syndrome during treatment with teduglutide.","volume":"40","author":"Kocoshis","year":"2016","journal-title":"J Parente Enteral Nutr."},{"key":"B25","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1097\/01.tp.0000757480.19792.d7","article-title":"Monocentric single-arm study on long-term safety and efficacy of teduglutide in SBS pediatric patients on long-term home-parenteral nutrition.","volume":"105","author":"Lambe","year":"2021","journal-title":"Transplantation."},{"key":"B26","doi-asserted-by":"crossref","DOI":"10.1097\/01.tp.0000576432.44757.42","article-title":"Teduglutide: intestinal rehabilitation in children, our initial experience.","volume":"103","author":"Martinez","year":"2019","journal-title":"Transplantation."},{"key":"B27","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0022-3468(80)80005-4","article-title":"Intestinal loop lengthening\u2014a technique for increasing small intestinal length.","volume":"15","author":"Bianchi","year":"1980","journal-title":"J Pediatr Surg."},{"key":"B28","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.dld.2019.11.013","article-title":"Understanding short bowel syndrome: current status and future perspectives.","volume":"52","author":"Massironi","year":"2020","journal-title":"Dig Liver Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"106","DOI":"10.2174\/1573396315666181129164112","article-title":"Non-transplant surgical management of short bowel syndrome in children: an overview.","volume":"15","author":"Coletta","year":"2019","journal-title":"Curr Pediatr Rev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.3945\/ajcn.2008.26007","article-title":"Pediatric short-bowel syndrome: the cost of comprehensive care.","volume":"88","author":"Spencer","year":"2008","journal-title":"Am J Clin Nutr."},{"key":"B31","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1177\/0148607116688437","article-title":"The relationship between parenteral nutrition and central line-associated bloodstream infections: 2009-2014.","volume":"42","author":"Fonseca","year":"2018","journal-title":"J Parenter Enteral Nutr."},{"key":"B32","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.clnu.2008.02.005","article-title":"Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction.","volume":"27","author":"Crenn","year":"2008","journal-title":"Clin Nutr."},{"key":"B33","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1177\/2050640617737632","article-title":"Citrulline as a marker of intestinal function and absorption in clinical settings: a systematic review and meta-analysis.","volume":"6","author":"Fragkos","year":"2018","journal-title":"United Eur Gastroenterol J."},{"key":"B34","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jpeds.2021.06.025","article-title":"Trends in pediatric intestinal failure: a multicenter, multinational study.","volume":"237","author":"Gattini","year":"2021","journal-title":"J Pediatr."}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2022.866518\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T07:02:30Z","timestamp":1655190150000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2022.866518\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,14]]},"references-count":34,"alternative-id":["10.3389\/fnut.2022.866518"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2022.866518","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,14]]},"article-number":"866518"}}